News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Elad Sharon: New framework to consider phase 1 clinical trials ⁦
Sep 30, 2024, 15:56

Elad Sharon: New framework to consider phase 1 clinical trials ⁦

Elad Sharon, Medical Oncologist at Dana-Farber, shared on X:

 

“Nagla Abdel Karim gives us a new framework to consider phase 1 clinical trials ⁦

Inova Health⁩’s Evolving Therapies meeting!”

Elad Sharon

Source: Elad Sharon/X

 

cancer Elad Sharon Nagla Abdel Karim OncoDaily Oncology
Special Coverage
Blog
Mar 31, 2025, 15:57
Register Today for the 2025 Breast Cancer Symposium
Blog
Mar 31, 2025, 15:45
Allison Betof Warner: Last Call for Abstracts to the 2025 SNO/ASCO CNS Metastasis Conference
Blog
Mar 31, 2025, 15:33
Luis Moreno Sánchez: Reirradiation in the Management of Locally Recurrent Rectal Adenocarcinoma
Blog
Mar 31, 2025, 15:29
Peter Pisters: Exciting groundbreaking in Sugar Land for MD Anderson Cancer Center's new facility
Societies
Mar 31, 2025, 15:22
Hilights from ELCC 2025
Blog
Mar 31, 2025, 15:14
Ted Yanagihara: Algorithm for Managing Anorectal Pain in Cancer Patients Undergoing Pelvic Radiotherapy
Blog
Mar 31, 2025, 14:52
Razelle Kurzrock: Toll-like receptor 3 - a double-edged sword
Blog
Mar 31, 2025, 14:52
Sachin Jain: The Hidden Cost of Middlemen in US Healthcare
Blog
Mar 31, 2025, 14:46
MCRC Director's Update - March 2025
Blog
Mar 31, 2025, 14:40
CAIRO Journal Club - Registration is Now Open for the Lung Cancer 360° Forum 7th Edition
Blog
Mar 31, 2025, 14:02
Highlights from NCCN2025
Blog
Mar 31, 2025, 13:50
Raymond Chan: More MRFF funding for Flinders University on dementia and cancer survivorship